日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia

RHOA 调节的 IGFBP2 促进 BCR-ABL1 慢性粒细胞白血病的侵袭并推动其进展

Hualei Zhang, Baohuan Cai, Yun Liu, Yating Chong, Atsuko Matsunaga, Stephanie Fay Mori, Xuexiu Fang, Eiko Kitamura, Chang-Sheng Chang, Ping Wang, John K Cowell, Tianxiang Hu

A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML

FGFR1 激酶的截短衍生物与 FLT3 和 KIT 协同作用,转化综合征型和新生型 AML 中的造血干细胞

Baohuan Cai, Yun Liu, Yating Chong, Stephanie Fay Mori, Atsuko Matsunaga, Hualei Zhang, Xuexiu Fang, Chang-Sheng Chang, John K Cowell, Tianxiang Hu

IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies

IRAK1调控的IFN-γ信号通路诱导MDSC,从而促进FGFR1驱动的血液系统恶性肿瘤的免疫逃逸。

Baohuan Cai ,Yun Liu ,Yating Chong ,Hualei Zhang ,Atsuko Matsunaga ,Xuexiu Fang ,Rafal Pacholczyk ,Gang Zhou ,John K Cowell ,Tianxiang Hu

Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome

PUMA 下调是干细胞白血病/淋巴瘤综合征对 FGFR1 抑制剂产生耐药性的原因

Yun Liu, Baohuan Cai, Yating Chong, Hualei Zhang, Chesley-Anne Kemp, Sumin Lu, Chang-Sheng Chang, Mingqiang Ren, John K Cowell, Tianxiang Hu

FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome

FGFR1融合激酶调控MYC表达促进干细胞白血病/淋巴瘤综合征的发展

Tianxiang Hu, Qing Wu, Yating Chong, Haiyan Qin, Candace J Poole, Jan van Riggelen, Mingqiang Ren, John K Cowell

Ferulic acid ameliorates nerve injury induced by cerebral ischemia in rats

阿魏酸改善大鼠脑缺血引起的神经损伤

Leiming Zhang, Hongsheng Wang, Tian Wang, Na Jiang, Pengfei Yu, Yating Chong, Fenghua Fu